Global Urokinase Market (2023-2028) by Type, Dose Strength, Indication, Applications, and Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Urokinase Market (2023-2028) by Type, Dose Strength, Indication, Applications, and Geography, Competitive Analysis,... Read more.
Terran Orbital Releases Enhanced Versions of Enterprise Bus
Continuing to set the standards for small satellites BOCA RATON, Fla.–(BUSINESS WIRE)–#aerospace–Terran Orbital Corporation (NYSE: LLAP) (“Terran... Read more.
NiSource Hosts Annual Supplier Day Event
Company continues to strengthen collaborative supplier partnerships COLUMBUS, Ohio–(BUSINESS WIRE)–NiSource Inc. (NYSE: NI), one of the leading fully... Read more.
Carter’s Announces First-Ever ‘Gift Wrapping Weekend,’ the Ultimate Holiday Hack
The trusted baby brand is giving parents and caregivers the ultimate holiday gift – a silent two-night hotel stay to destress ahead of the season ATLANTA–(BUSINESS... Read more.
Global Graves’ Disease Drug Pipeline Research Report 2023: Comprehensive Insights About 8+ Companies and 10+ Pipeline Drugs – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Graves’ Disease – Pipeline Insight, 2023” drug pipelines has been added to ResearchAndMarkets.com’s... Read more.
Desktop Metal Announces Third Quarter 2023 Financial Results
Completed $100 million in cost reductions announced in June 2022 ahead of schedule Revenue of $42.8 million compared to $47.1 million in the same quarter a year... Read more.
Global Blue Releases the Monthly Tax Free Shopping Business Update for October 2023
SIGNY, Switzerland–(BUSINESS WIRE)–New data from Global Blue (NYSE:GB) reveals that the global dynamic recovery for Tax Free Shopping has remained solid... Read more.
Superior Drilling Products Reports Third Quarter 2023 Results
Third quarter revenue was $5.1 million Strengthened international technical support group to capitalize on significant near- and long-term opportunities Creating... Read more.
Schizoaffective Disorder Drug Pipeline Research Report 2023 Featuring Lyndra Therapeutics, Luye Pharma Group, BioXcel Therapeutics, & Reviva Pharma – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Schizoaffective Disorder – Pipeline Insight, 2023” clinical trials has been added to ResearchAndMarkets.com’s... Read more.
GoodRx Reports Third Quarter 2023 Results
SANTA MONICA, Calif.–(BUSINESS WIRE)–GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), a leading resource for healthcare savings... Read more.